Jedd Wolchok

60PUBLICATIONS
450CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsInnate immunityMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Jun 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

|Jun 22, 2026
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.

|Jun 15, 2026
Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer.

|Jan 07, 2026
IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Danny N Khalil, Ricardo Gomez, Amit Regev

|Nov 17, 2025
Thrombospondin-1-CD47 signaling contributes to the development of T cell exhaustion in cancer.

Chien-Huan Weng, Anais Assouvie, Lauren Dong

|Aug 08, 2025
Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial.

Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto

Pageof 10

Frequent Collaborators

30 joint publications

Taha Merghoub

8 joint publications

Sadna Budhu

8 joint publications

Roberta Zappasodi

7 joint publications

Alexander Noor Shoushtari